Covered recipient · General Payments record

ROBERT M HAN

Allopathic & Osteopathic Physicians Internal Medicine

NPI: 1669714242
CMS profile: 1379325
Location: OWOSSO, MI

General Payments · PY2019–2024

$2,661.84

Reported across 104 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,358.71

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,358.71	55

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
Acerta Pharma LLC	$287.62	9
Lilly USA, LLC	$211.31	6
ABBVIE INC.	$165.50	4
PFIZER INC.	$97.42	5
Otsuka America Pharmaceutical, Inc.	$78.29	4
Merck Sharp & Dohme Corporation	$76.62	4
Amgen Inc.	$69.90	4
NOVARTIS PHARMACEUTICALS CORPORATION	$44.22	2
Boehringer Ingelheim Pharmaceuticals, Inc.	$42.88	2
Exact Sciences Corporation	$42.64	2
Novo Nordisk AS	$38.69	2
Vanda Pharmaceuticals Inc.	$35.79	1
GlaxoSmithKline, LLC.	$33.66	2
Antares Pharma, Inc.	$30.06	2
Corcept Therapeutics	$21.44	1
Axsome Therapeutics, Inc.	$19.48	1
ITI, Inc.	$18.14	1
Averitas Pharma Inc.	$16.78	1
Collegium Pharmaceutical, Inc.	$14.17	1
SCPHARMACEUTICALS INC.	$14.10	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2019	$11.81	1
PY2020	$48.47	3
PY2022	$107.09	6
PY2023	$1,135.76	39
PY2024	$1,358.71	55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019 2020 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$113.62	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1103872477	CMS
ABBVIE INC.	$7.70	01/30/2024	Food and Beverage	Undisputed	01/23/2026	1103872479	CMS
ABBVIE INC.	$17.81	07/31/2024	Food and Beverage	Undisputed	01/23/2026	1103872481	CMS
ABBVIE INC.	$26.37	10/09/2024	Food and Beverage	Undisputed	01/23/2026	1103872483	CMS
Amgen Inc.	$17.83	02/21/2024	Food and Beverage	Undisputed	01/23/2026	1115698792	CMS
Amgen Inc.	$18.67	04/09/2024	Food and Beverage	Undisputed	01/23/2026	1117572265	CMS
Amgen Inc.	$13.14	09/18/2024	Food and Beverage	Undisputed	01/23/2026	1117572267	CMS
Amgen Inc.	$20.26	11/19/2024	Food and Beverage	Undisputed	01/23/2026	1117572269	CMS
Antares Pharma, Inc.	$15.87	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1146462354	CMS
Antares Pharma, Inc.	$14.19	10/01/2024	Food and Beverage	Undisputed	01/23/2026	1146462358	CMS
AstraZeneca Pharmaceuticals LP	$82.97	01/13/2024	Food and Beverage	Undisputed	01/23/2026	1104383169	CMS
AstraZeneca Pharmaceuticals LP	$101.68	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1104553016	CMS
AstraZeneca Pharmaceuticals LP	$13.71	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1104782792	CMS
AstraZeneca Pharmaceuticals LP	$15.44	02/14/2024	Food and Beverage	Undisputed	01/23/2026	1104311996	CMS
AstraZeneca Pharmaceuticals LP	$16.97	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1104625370	CMS
AstraZeneca Pharmaceuticals LP	$14.16	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1104233147	CMS
AstraZeneca Pharmaceuticals LP	$13.92	06/20/2024	Food and Beverage	Undisputed	01/23/2026	1105571411	CMS
AstraZeneca Pharmaceuticals LP	$15.23	10/22/2024	Food and Beverage	Undisputed	01/23/2026	1105719096	CMS
AstraZeneca Pharmaceuticals LP	$13.54	12/18/2024	Food and Beverage	Undisputed	01/23/2026	1104783058	CMS
Averitas Pharma Inc.	$16.78	04/24/2024	Food and Beverage	Undisputed	01/23/2026	1133428908	CMS
Axsome Therapeutics, Inc.	$19.48	05/14/2024	Food and Beverage	Undisputed	01/23/2026	1148316676	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$25.15	03/21/2024	Food and Beverage	Undisputed	01/23/2026	1118103985	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$17.73	05/22/2024	Food and Beverage	Undisputed	01/23/2026	1118103983	CMS
Collegium Pharmaceutical, Inc.	$14.17	07/18/2024	Food and Beverage	Undisputed	01/23/2026	1135278401	CMS
Corcept Therapeutics	$21.44	11/26/2024	Food and Beverage	Undisputed	01/23/2026	1117772267	CMS
Exact Sciences Corporation	$21.64	03/13/2024	Food and Beverage	Undisputed	01/23/2026	1114518240	CMS
Exact Sciences Corporation	$21.00	10/29/2024	Food and Beverage	Undisputed	01/23/2026	1114518243	CMS
GlaxoSmithKline, LLC.	$14.79	03/20/2024	Food and Beverage	Undisputed	01/23/2026	1116456815	CMS
GlaxoSmithKline, LLC.	$18.87	09/19/2024	Food and Beverage	Undisputed	01/23/2026	1116277728	CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$18.14	03/14/2024	Food and Beverage	Undisputed	01/23/2026	1143238628	CMS
Lilly USA, LLC	$19.41	02/27/2024	Food and Beverage	Undisputed	01/23/2026	1135384151	CMS
Lilly USA, LLC	$124.27	03/19/2024	Food and Beverage	Undisputed	01/23/2026	1135396143	CMS
Lilly USA, LLC	$15.15	05/28/2024	Food and Beverage	Undisputed	01/23/2026	1135356379	CMS
Lilly USA, LLC	$18.63	08/20/2024	Food and Beverage	Undisputed	01/23/2026	1135370382	CMS
Lilly USA, LLC	$16.94	10/03/2024	Food and Beverage	Undisputed	01/23/2026	1135396827	CMS
Lilly USA, LLC	$16.91	12/09/2024	Food and Beverage	Undisputed	01/23/2026	1135361022	CMS
Merck Sharp & Dohme LLC	$18.51	01/03/2024	Food and Beverage	Undisputed	01/23/2026	1141618816	CMS
Merck Sharp & Dohme LLC	$25.86	06/26/2024	Food and Beverage	Undisputed	01/23/2026	1141919776	CMS
Merck Sharp & Dohme LLC	$14.98	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1141971641	CMS
Merck Sharp & Dohme LLC	$17.27	11/06/2024	Food and Beverage	Undisputed	01/23/2026	1141979809	CMS
Novartis Pharmaceuticals Corporation	$22.11	05/10/2024	Food and Beverage	Undisputed	01/23/2026	1086807895	CMS
Novartis Pharmaceuticals Corporation	$22.11	07/17/2024	Food and Beverage	Undisputed	01/23/2026	1086807915	CMS
Novo Nordisk Inc	$17.80	01/10/2024	Food and Beverage	Undisputed	01/23/2026	1097074176	CMS
Novo Nordisk Inc	$20.89	05/08/2024	Food and Beverage	Undisputed	01/23/2026	1096729790	CMS
Otsuka America Pharmaceutical, Inc.	$20.50	04/24/2024	Food and Beverage	Undisputed	01/23/2026	1118904591	CMS
Otsuka America Pharmaceutical, Inc.	$19.57	10/09/2024	Food and Beverage	Undisputed	01/23/2026	1118904593	CMS
Otsuka America Pharmaceutical, Inc.	$20.45	11/20/2024	Food and Beverage	Undisputed	01/23/2026	1118904595	CMS
Otsuka America Pharmaceutical, Inc.	$17.77	12/11/2024	Food and Beverage	Undisputed	01/23/2026	1118904597	CMS
PFIZER INC.	$21.14	01/17/2024	Food and Beverage	Undisputed	01/23/2026	1131526870	CMS
PFIZER INC.	$19.14	05/29/2024	Food and Beverage	Undisputed	01/23/2026	1131452368	CMS
PFIZER INC.	$20.14	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1131523267	CMS
PFIZER INC.	$18.00	10/08/2024	Food and Beverage	Undisputed	01/23/2026	1131566469	CMS
PFIZER INC.	$19.00	12/19/2024	Food and Beverage	Undisputed	01/23/2026	1131551822	CMS
SCPHARMACEUTICALS INC.	$14.10	02/01/2024	Food and Beverage	Undisputed	01/23/2026	1132245642	CMS
Vanda Pharmaceuticals Inc.	$35.79	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1133905425	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2019, 2020, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.